The Latest Breaking News from Pfizer

Upcoming clinical trial results will give investors a much better look into Pfizer’s operational health.

Football legend Joe Montana joins SI's Claudette Montana, on behalf of Pfizer, to discuss Brock Purdy's future in San Francisco, Marcus Freeman and Notre Dame,

Pfizer tock edged lower Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat.

The Dow Jones dropped Tuesday as China imposed tariffs on U.S. imports in response to President Trump's tariffs. Palantir surged on earnings.

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs.

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

Last week was extremely busy on the earnings front, so this week is a little more sedate. That being said, we still have some big names due to report including Amazon, Alphabet, Walt Disney, Palantir Technologies, Advanced Micro Devices, Microstrategy, Uber Technologies and Pfizer.

A guide to the people and activist organizations who paved the way for Donald Trump's attacks on diversity practices in corporate America.

In fourth part of the inquiry, questons were asked about vaccine trials, procurement and the UK’s preparedness for future pandemics